Affiliation:
1. V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology
2. V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology; I.P. Pavlov First St. Petersburg State Medical University
Abstract
The problem of the simultaneous history of several diseases, including somatic ones, in one patient is of high relevance in the context of the prevention, diagnosis and treatment of mental disorders. The complexity and multivariance of the relationships of concomitant diseases does not allow us to evaluate their complex interaction according to the concept of comorbidity. The concept of multimorbidity is convenient and promising for studying various aspects of the combination of both mental disorders and their associations with somatic pathology. However, at present, most studies in the area of multimorbidity are based primarily on epidemiological assessments, while much less attention has been paid to the mechanisms of multimorbid conditions. In this review, we consider the main recent approaches related to the study of the multimorbidity of mental disorders and somatic diseases in order to determine the optimal research strategies in this area. Further studies of the etiopathogenetic aspects of multimorbidity, the mechanisms of multimorbid clusters, and the aspects of the course and prognosis of multimorbid diseases are necessary to optimize the concept for both scientific projects and clinical practice. The most important directions for future research on the phenomenon of multimorbidity of mental disorders and somatic diseases are: 1) the study of their shared genetic and molecular mechanisms of development; 2) clinical and fundamental prospective studies of the manifestation, concomitant course and outcomes of multimorbid diseases; 3) study of the effectiveness and tolerability of psychopharmacotherapy in multimorbid patients with various somatic diagnoses, considering the complex interaction of the drugs used.
Publisher
V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology
Reference42 articles.
1. Kasyanov ED, Rakitko AS, Rukavishnikov GV, Golimbet VE, Shmukler AB, Iliinsky VV, Neznanov NG, Kibitov AO, Mazo GE. Contemporary GWAS studies of depression: the critical role of phenotyping. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2022;122(1):50-61. (In Russ.). https://doi.org/10.17116/jnevro202212201150.
2. Kibitov AO, Mazo GE, Rakitko AS, Kasyanov ED, Rukavishnikov GV, Ilinsky VV, Golimbet VE, Shmukler AB, Neznanov NG. GWAS-based polygenic risk scores for depression with clinical validation: methods and study design in the Russian population. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2020;120(11):131-140. (In Russ.). https://doi.org/10.17116/jnevro2020120111131
3. Neznanov NG, Kibitov AO, Rukavishnikov GV, Mazo GE. The prognostic role of depression as a predictor of chronic somatic diseases manifestation. Terapevticheskii arkhiv. 2018;90(12):122-132. (In Russ.). https://doi.org/10.26442/00403660.2018.12.000019
4. Neznanov N.G., Mazo G.E., Kibitov A.O. Depressiya i risk razvitiya somaticheskih zabolevanij. Rukovodstvo dlya vrachej. Pod red. N.G. Neznanova, G.E. Mazo, A.O. Kibitova. M.: Special'noe izdatel'stvo medicinskih knig; 2018. (In Russ.).
5. Neznanov NG, Rukavishnikov GV, Kaysanov ED, Zhilyaeva TV, Mazo GE. New approach to mental disorders systematics: starting point or point of view? Obozrenie psihiatrii i medicinskoj psihologii imeni V.M. Bekhtereva. 2020;(3):3-10. (In Russ.). https://doi.org/10.31363/2313-7053-2020-3-3-10